X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NATCO PHARMA DR. DATSONS LABS/
NATCO PHARMA
 
P/E (TTM) x -10.9 30.8 - View Chart
P/BV x 0.2 23.3 0.7% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   NATCO PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NATCO PHARMA
Mar-14
DR. DATSONS LABS/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs126877 14.3%   
Low Rs31424 7.3%   
Sales per share (Unadj.) Rs133.0223.4 59.5%  
Earnings per share (Unadj.) Rs0.231.1 0.5%  
Cash flow per share (Unadj.) Rs6.640.3 16.4%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8219.5 58.7%  
Shares outstanding (eoy) m31.6633.07 95.7%   
Bonus/Rights/Conversions FCCBPA-  
Price / Sales ratio x0.62.9 20.2%   
Avg P/E ratio x516.120.9 2,465.9%  
P/CF ratio (eoy) x11.816.1 73.3%  
Price / Book Value ratio x0.63.0 20.5%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m2,47721,504 11.5%   
No. of employees `000NANA-   
Total wages/salary Rs m561,128 5.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,2117,389 57.0%  
Other income Rs m79167 47.1%   
Total revenues Rs m4,2897,556 56.8%   
Gross profit Rs m5691,793 31.7%  
Depreciation Rs m204304 67.1%   
Interest Rs m430366 117.5%   
Profit before tax Rs m131,290 1.0%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6309 2.0%   
Profit after tax Rs m51,027 0.5%  
Gross profit margin %13.524.3 55.6%  
Effective tax rate %48.023.9 200.7%   
Net profit margin %0.113.9 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,8523,681 186.1%   
Current liabilities Rs m6,7113,123 214.9%   
Net working cap to sales %3.37.6 44.3%  
Current ratio x1.01.2 86.6%  
Inventory Days Days16189 179.8%  
Debtors Days Days31859 542.7%  
Net fixed assets Rs m3,6737,685 47.8%   
Share capital Rs m317331 95.7%   
"Free" reserves Rs m3,7616,670 56.4%   
Net worth Rs m4,0787,259 56.2%   
Long term debt Rs m1,671955 175.0%   
Total assets Rs m12,63311,957 105.6%  
Interest coverage x1.04.5 22.8%   
Debt to equity ratio x0.40.1 311.5%  
Sales to assets ratio x0.30.6 53.9%   
Return on assets %3.411.7 29.5%  
Return on equity %0.114.2 0.8%  
Return on capital %7.720.7 37.0%  
Exports to sales %22.939.4 58.2%   
Imports to sales %14.35.7 250.8%   
Exports (fob) Rs m9642,908 33.2%   
Imports (cif) Rs m602421 142.9%   
Fx inflow Rs m9643,445 28.0%   
Fx outflow Rs m607703 86.4%   
Net fx Rs m3572,743 13.0%   
CASH FLOW
From Operations Rs m1,3451,440 93.4%  
From Investments Rs m-2,256-1,089 207.1%  
From Financial Activity Rs m-1,200-353 340.2%  
Net Cashflow Rs m-2,111-1 141,657.7%  

Share Holding

Indian Promoters % 4.5 52.0 8.7%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 1.4 16.6 8.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 26.0 361.9%  
Shareholders   20,807 25,395 81.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GSK PHARMA  ASTRAZENECA PHARMA  DIVIS LABORATORIES  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Crash in Bitcoin, Correction in MidCap and SmallCap Indices and Top Stocks in Action Today(Pre-Open)

The past year has seen the BSE MidCap and BSE SmallCap indices surging by 43.1% and 57.1% respectively. Taking a two year view these indices have produced mind-boggling return of 75.3% .

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS